Bank of Ningbo
VC Fund
Ningbo, China
Bank of Ningbo is a VC fund in Ningbo focused on Gaming and Software. Founded on 10 April 1997, Bank of Ningbo became the first listed city commercial bank in China on 19 July 2007.Bank of Ningbo has set up 13 branches outside Ningbo district in the cities of Shanghai, Hangzhou, Nanjing, Shenzhen, Suzhou, Wenzhou, Beijing, Wuxi, Jinhua, Shaoxing, Taizhou, Jiaxing and Lishui, with an overall 346 business networks.Bank of Ningbo also successfully set up Maxwealth Fund Management Co., Ltd. in November 2013; Maxwealth Financial Leasing Co., Ltd., the wholly-owned subsidiary of Bank of Ningbo was officially opened in May 2015.After 22 years’ growth since its establishment, along with the rapid growth of Chinese economy and the strong support from its customers and all sectors of society, Bank of Ningbo has achieved substantial development. The Bank has developed into a public listed regional bank with total net capital of over RMB 100 billion, total asset of over RMB 1,100 billion, and more than 15,000 employees, ranking among the World’s Top 200 banks.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Bank of Ningbo invests in
Stages Bank of Ningbo invests in
Countries Bank of Ningbo invests in
Investment Focus
Industry
- Gaming 1 (33%)
- Software 1 (33%)
- Biotechnology 1 (33%)
- Pharmaceutical 1 (33%)
- Web Development 1 (33%)
Stage
- Series B 1 (33%)
- Debt Financing 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
HemaCell
|
Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish aplatform using platelet cells as a drug delivery carrier. | $17.1M / Debt Financing / Dec 26, 2025 | |
|
HemaCell
|
Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish aplatform using platelet cells as a drug delivery carrier. | Debt Financing / Dec 19, 2023 | |
Shinezone
|
Shinezone is focusing on game development and operation .They believe that the game is an art, only focus on every detail to create the ultimate user experience, at the same time they listen to the voice from the user, With the user to create a boutique game. Hyatt set from the world's top game company's outstanding talent, the core teammembers are equipped with high-quality management and skills level. | $8.1M / Series B / Feb 17, 2017 |
Co-Investors
China Construction Bank
2 deals together
China CITIC Bank
1 deal together
China Fortune Securities
1 deal together
China Merchants Bank
1 deal together
High-Tech Venture Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bank of Ningbo invest in?
Bank of Ningbo invests primarily in Gaming, Software and Biotechnology startups, most often at Series B and Debt Financing stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Bank of Ningbo last invest?
The most recent investment recorded for Bank of Ningbo closed in Dec 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
